Sinopharm Tech Holdings Limited (8156.HK)
HKD 0.1
(0.0%)
HKD 0.1
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.73 Million | -36.76 Million | -6.21 Million | 23.92 Million | -33.85 Million | -30.13 Million |
| Net Income | -11.4 Million | -94.15 Million | -111.06 Million | -165.38 Million | -47.93 Million | -73.39 Million |
| Depreciation & Amortization | 2 Million | 2.42 Million | 10.45 Million | 9.26 Million | 11.1 Million | 12.78 Million |
| Deferred income taxes | 94.62 Million | 72.44 Million | 47.18 Million | 126.63 Million | - | 5.75 Million |
| Stock-based compensation | 2.48 Million | 4.44 Million | 4.29 Million | 8.26 Million | - | 25 Thousand |
| Change in working capital | -78.92 Million | -9.37 Million | 17.57 Million | 26.98 Million | -11.01 Million | 14.2 Million |
| Other non-cash items | -4.05 Million | -12.55 Million | 25.34 Million | 18.15 Million | 13.99 Million | 10.49 Million |
| Investing Cash Flow | 2000.00 | -85 Thousand | -5.04 Million | -23.39 Million | 25 Thousand | -364 Thousand |
| Investments in PPE | - | -121 Thousand | -10.11 Million | -23.39 Million | - | -456 Thousand |
| Acquisitions | - | -275 Thousand | 7.46 Million | 1.44 Million | 10 Thousand | 79 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 2000.00 | 311 Thousand | -2.4 Million | -1.43 Million | 15 Thousand | 13 Thousand |
| Financing Cash Flow | -4.51 Million | 32.23 Million | 12.45 Million | -299 Thousand | 36.89 Million | 20.91 Million |
| Debt repayment | -1.01 Million | -13.8 Million | -2.34 Million | -15.6 Million | -194 Thousand | -188 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 8 Million | 39.98 Million | - |
| Other Financing Activities | -3.5 Million | 46.03 Million | 14.79 Million | 7.3 Million | -2.89 Million | 20.91 Million |
| Accounts receivables | -54.79 Million | -26.84 Million | -2.38 Million | -16.68 Million | -8.82 Million | -1.61 Million |
| Accounts payables | -23.95 Million | 17.77 Million | 18.9 Million | 50.99 Million | -2.44 Million | 15.27 Million |
| Inventory | -173 Thousand | -309 Thousand | 1.05 Million | -7.32 Million | 243 Thousand | 541 Thousand |
| Other working capital | -23.95 Million | - | - | - | - | 13.66 Million |
| Cash at beginning of period | 2.99 Million | 7.48 Million | 6.74 Million | 6.64 Million | 4.71 Million | 14.3 Million |
| Cash at end of period | 1.77 Million | 2.99 Million | 7.48 Million | 6.74 Million | 6.64 Million | 4.71 Million |
| Capital Expenditure | - | -121 Thousand | -10.11 Million | -23.39 Million | - | -456 Thousand |
| Effect of forex changes on cash | -1.43 Million | 120 Thousand | -461 Thousand | -128 Thousand | -1.13 Million | 3000.00 |
| Net cash flow / Change in cash | -1.21 Million | -4.49 Million | 736 Thousand | 100 Thousand | 1.92 Million | -9.58 Million |
| Free Cash Flow | 4.73 Million | -36.88 Million | -16.32 Million | 523 Thousand | -33.85 Million | -30.59 Million |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -533 Thousand | -2.34 Million | -19.72 Million | -11.4 Million | -6.32 Million | 11.02 Million |
| Depreciation & Amortization | 240 Thousand | - | 1.31 Million | 2 Million | - | 692 Thousand |
| Deferred income taxes | - | - | - | 94.62 Million | - | - |
| Stock-based compensation | - | - | 875 Thousand | 2.48 Million | 865 Thousand | - |
| Change in working capital | - | - | - | -78.92 Million | - | - |
| Other non-cash items | 533 Thousand | 2.34 Million | 18.84 Million | -4.05 Million | 5.45 Million | -11.02 Million |
| Investing Cash Flow | - | - | 23 Thousand | 2000.00 | - | -23 Thousand |
| Investments in PPE | - | - | 23 Thousand | - | - | -23 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 2000.00 | - | - |
| Financing Cash Flow | 8.27 Million | - | -727 Thousand | -4.51 Million | - | -290 Thousand |
| Debt repayment | -8.27 Million | - | - | -1.01 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | -3.5 Million | - | - |
| Accounts receivables | - | - | - | -54.79 Million | - | - |
| Accounts payables | - | - | - | -23.95 Million | - | - |
| Inventory | - | - | - | -173 Thousand | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.77 Million | - | 7.28 Million | 2.99 Million | - | 2.99 Million |
| Cash at end of period | 8.5 Million | - | 1.77 Million | 1.77 Million | 865 Thousand | 7.28 Million |
| Capital Expenditure | - | - | 23 Thousand | - | - | -23 Thousand |
| Effect of forex changes on cash | - | - | 5.06 Million | -1.43 Million | - | -115 Thousand |
| Net cash flow / Change in cash | 6.72 Million | - | -5.5 Million | -1.21 Million | 865 Thousand | 4.29 Million |
| Free Cash Flow | -1.31 Million | - | -3.46 Million | 4.73 Million | 865 Thousand | 4.69 Million |
6526
019180
KILITCH
NRPI
BLTA
1224